skip to main content

Survival and prognosis of young adults with gastric cancer

Cormedi, Marina Candido Visontai; Katayama, Maria Lucia Hirata; Guindalini, Rodrigo Santa Cruz; Faraj, Sheila Friedrich; Folgueira, Maria Aparecida Azevedo Koike

Clinics; v. 73 n. Suppl. 1 (2018); e651s

Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo 2019-02-14

Acesso online

  • Título:
    Survival and prognosis of young adults with gastric cancer
  • Autor: Cormedi, Marina Candido Visontai; Katayama, Maria Lucia Hirata; Guindalini, Rodrigo Santa Cruz; Faraj, Sheila Friedrich; Folgueira, Maria Aparecida Azevedo Koike
  • Assuntos: Stomach Neoplasms; Survival; Young Adult
  • É parte de: Clinics; v. 73 n. Suppl. 1 (2018); e651s
  • Descrição: OBJECTIVES: Survival data for young adults (YA) with gastric cancer is conflicting and scarce in Brazil. The aim of this study was to compare the clinicopathological factors and survival rates of younger and older patients with gastric cancer. METHODS: Hospital registries for 294 gastric cancer patients from a reference cancer hospital in Sa˜o Paulo, Brazil, were consulted for the retrieval of clinicopathological information and follow-up time. Patients were placed into the following groups: YA (p40 years; N=71), older adult (OA: 41 to 65 years; N=129) and elderly (E: X66 years; N=94). Differences were assessed through Pearson’s w2 test, Kaplan-Meier analysis, Log rank test and Cox regression. RESULTS: More YA were diagnosed with advanced disease (clinical stage III/IV: 86.7% YA, 69.9% OA, and 67% E); however, fewer E patients underwent surgery (64.3% YA, 72.7% OA, and 52.4% E). The median overall survival among all patients was 16 months, and the overall survival rate was not significantly different among the age groups (p=0.129). There were no significant differences in the disease-free survival rate. Metastatic disease at diagnosis (HR=4.84; po0.01) was associated with an increased hazard of death for YA. CONCLUSION: Overall survival was similar among age groups. Metastatic disease at diagnosis was the only factor associated with a poorer prognosis in YA. These results suggest that younger patients deserve special attention regarding the detection of early stage disease.
  • Títulos relacionados: https://www.revistas.usp.br/clinics/article/view/154742/150774
  • Editor: Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
  • Data de criação/publicação: 2019-02-14
  • Formato: Adobe PDF
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.